Nisa Investment Advisors
GNMK

Nisa Investment Advisors’s GenMark Diagnostics, Inc GNMK Stock Holding History

Nisa Investment Advisors’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,350
Closed -$152 – 2427
2021
Q1 		$152 Hold
6,350
– – ﹤0.01% 1574
2020
Q4 		$93K Buy
6,350
+900
+17% +$11.9K ﹤0.01% 1765
2020
Q3 		$77K Buy
5,450
+2,250
+70% +$34.4K ﹤0.01% 1636
2020
Q2 		$47K Buy
3,200
+800
+33% +$8.13K ﹤0.01% 1602
2020
Q1 		$10K Buy
+2,400
New +$11.3K ﹤0.01% 1858

Nisa Investment Advisors's GNMK Position: Q2 2021 in Review

Nisa Investment Advisors sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 6,350 shares — an estimated $152 sold.

Nisa Investment Advisors first reported a position in GNMK in Q1 2020 and held it in 5 quarters. The position peaked at $93K in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Nisa Investment Advisors reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Nisa Investment Advisors sold 6,350 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $152.
  • Nisa Investment Advisors first reported a position in GenMark Diagnostics, Inc in Q1 2020 and held it in 5 quarters.
  • Nisa Investment Advisors's GenMark Diagnostics, Inc position peaked at $93K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Nisa Investment Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.